Related Experiment Video
Updated: Aug 9, 2026
08:47
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
Allergic rhinitis management: what's next?
Farnaz Tabatabaian1, Thomas B Casale1
1a Division of Allergy and Immunology, Department of Internal Medicine , Organization University of South Florida , Tampa , FL , USA.
Expert Review of Clinical Immunology
|February 7, 2018
Summary
Allergic rhinitis (AR) treatments are evolving beyond traditional immunotherapy. Novel therapies are emerging to offer safer and more effective options for patients suffering from this common condition.
Area of Science:
- Immunology
- Otolaryngology
- Allergy & Asthma
Background:
- Allergic rhinitis (AR) presents with symptoms like congestion, postnasal drainage, sneezing, and rhinorrhea.
- AR significantly impacts global productivity and causes considerable morbidity.
- Current treatments often rely on allergen-specific immunotherapy (subcutaneous or sublingual).
Purpose of the Study:
- To review current data on allergen-specific immunotherapy for allergic rhinitis.
- To explore novel and emerging therapeutic options for AR.
- To discuss advancements that may offer safer and more effective treatment strategies.
Main Methods:
- Review of existing data on allergic rhinitis therapies.
- Analysis of recent advancements in novel treatment development.
- Discussion of newly approved or investigational therapies.
Main Results:
- Allergen-specific immunotherapy remains a cornerstone therapy for altering the course of AR.
- Significant progress has been made in developing alternative therapeutic approaches.
- Novel therapies under investigation or recently approved show promise for improved efficacy and safety.
Conclusions:
- Novel therapies are under investigation for allergic rhinitis, a condition impairing quality of life.
- These advancements aim to provide better therapeutic options for patients.
- The future of AR treatment may include more effective and safer alternatives.
Related Concept Videos
01:16Drugs Used in Upper Respiratory Disorders: Overview
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:30Asthma-IV: Nursing Management
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...